$0.63
6.21%
Nasdaq, Sep 18, 04:00 pm EDT. Closed.
ISIN
BE0974461940
Symbol
MDXH

MDxHealth Target price 2026 - Analyst rating & recommendation

MDxHealth Classifications & Recommendation

Buy
75%
Hold
25%

MDxHealth Price Target

Target Price $2.04
Price $0.63
Potential
Number of Estimates 7
7 Analysts have issued a price target MDxHealth 2027 . The average MDxHealth target price is $2.04. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 9 Analysts recommend MDxHealth to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MDxHealth stock has an average upside potential 2027 of . Most analysts recommend the MDxHealth stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 107.88 113.32
19.80% 5.04%
EBITDA Margin -5.59% -8.26%
70.16% 47.78%
Net Margin -31.07% -27.28%
26.50% 12.20%

8 Analysts have issued a sales forecast MDxHealth 2026 . The average MDxHealth sales estimate is

$113m
unlock
. This is
18.48% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$118m 14.80%
unlock
, the lowest is
$108m 22.45%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $108m 19.80%
2026
$113m 5.04%
unlock
2027
$128m 13.25%
unlock
2028
$140m 8.77%
unlock
2029
$154m 10.19%
unlock
2030
$157m 1.83%
unlock

8 Analysts have issued an MDxHealth EBITDA forecast 2026. The average MDxHealth EBITDA estimate is

$-9.4m
unlock
. This is
44.06% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-3.2m 81.18%
unlock
, the lowest is
$-14.5m 13.36%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-6.0m 64.26%
2026
$-9.4m 55.28%
unlock
2027
$2.2m 123.53%
unlock
2028
$10.5m 374.58%
unlock
2029
$12.0m 15.10%
unlock
2030
$17.4m 44.72%
unlock

EBITDA Margin

2025 -5.59% 70.16%
2026
-8.26% 47.78%
unlock
2027
1.72% 120.82%
unlock
2028
7.49% 335.47%
unlock
2029
7.82% 4.41%
unlock
2030
11.12% 42.20%
unlock

8 MDxHealth Analysts have issued a net profit forecast 2026. The average MDxHealth net profit estimate is

$-30.9m
unlock
. This is
31.84% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-24.8m 45.29%
unlock
, the lowest is
$-39.8m 12.33%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-33.5m 11.95%
2026
$-30.9m 7.79%
unlock
2027
$-16.1m 47.78%
unlock
2028
$-13.1m 18.84%
unlock

Net Margin

2025 -31.07% 26.50%
2026
-27.28% 12.20%
unlock
2027
-12.57% 53.92%
unlock
2028
-9.38% 25.38%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.67 -0.60
42.24% 10.45%
P/E negative
EV/Sales 1.30

8 Analysts have issued a MDxHealth forecast for earnings per share. The average MDxHealth EPS is

$-0.60
unlock
. This is
29.41% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.48 43.53%
unlock
, the lowest is
$-0.77 9.41%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.67 42.24%
2026
$-0.60 10.45%
unlock
2027
$-0.31 48.33%
unlock
2028
$-0.26 16.13%
unlock

P/E ratio

Current -0.74 77.70%
2026
-1.05 41.66%
unlock
2027
-2.01 91.43%
unlock
2028
-2.47 22.89%
unlock

Based on analysts' sales estimates for 2026, the MDxHealth stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.06 33.75%
2026
1.30 22.17%
unlock
2027
1.14 11.70%
unlock
2028
1.05 8.06%
unlock
2029
0.95 9.26%
unlock
2030
0.94 1.79%
unlock

P/S ratio

Current 0.43 65.30%
2026
0.53 22.66%
unlock
2027
0.47 11.69%
unlock
2028
0.43 8.07%
unlock
2029
0.39 9.24%
unlock
2030
0.38 1.82%
unlock

Current MDxHealth Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BTIG
Locked
Locked
Locked Aug 21 2026
Lake Street
Locked
Locked
Locked Aug 14 2026
BTIG
Locked
Locked
Locked May 14 2026
Lake Street
Locked
Locked
Locked May 14 2026
TD Cowen
Locked
Locked
Locked May 14 2026
BTIG
Locked
Locked
Locked Dec 23 2025
BTIG
Locked
Locked
Locked Nov 13 2025
Analyst Rating Date
Locked
BTIG:
Locked
Locked
Aug 21 2026
Locked
Lake Street:
Locked
Locked
Aug 14 2026
Locked
BTIG:
Locked
Locked
May 14 2026
Locked
Lake Street:
Locked
Locked
May 14 2026
Locked
TD Cowen:
Locked
Locked
May 14 2026
Locked
BTIG:
Locked
Locked
Dec 23 2025
Locked
BTIG:
Locked
Locked
Nov 13 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today